This study assesses comparative resource use for patients given a new diagnosis of nonvalvular atrial fibrillation treated with dabigatran or warfarin in a real-world setting.
Sameer Ghate, PhD
Advertisement
Articles by Sameer Ghate, PhD
Advertisement
Latest Updated Articles
- Resource Use Among Nonvalvular Atrial Fibrillation Patients
October 18th 2016
Advertisement
Advertisement
Trending on Pharmacy Times
1
COVID-19 Vaccination in Medically Complex Adults
2
The KIT D816V Mutation: Unlocking the Biology of Systemic Mastocytosis
3
Closing the Calcium Gap: How Pharmacists Can Guide Patients Toward Better Bone Health
4
Generic Semaglutide May Make GLP-1 Therapy Cost-Effective in T2D
5